4DMedical Ltd (ASX:4DX)
A$ 4.36 +0.11 (+2.59%) Market Cap: 2.54 Bil Enterprise Value: 2.49 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

4DMedical Ltd Contextflow Acquisition Webinar Transcript

Jun 09, 2026 / 01:00AM GMT
Release Date Price: A$4.01 (+1.01%)
John Hester
Bell Potter Securities Ltd - Analyst

Thank you, operator, and welcome, everyone, to today's conference. My name is John Hester from Bell Potter. And I'm joined today by the CEO of 4DMedical, Dr. Andreas Fouras. Also joining him is Julian Sutton, the CFO; and Chief Commercialization Officer, Matthew Tucker. Good afternoon and good morning, gentlemen, and welcome.

Our mission today is to discuss the company's recent commercialization progress, highlighted by three material announcements over the last months. These are, number one, the CLEAR study targeting the market currently serviced by CT pulmonary angiogram for the diagnosis of pulmonary embolism amongst a range of other lines.

Second, we're going to discuss the recent acquisition of contextflow, marking 40 Medical's entry into the medical imaging market in Europe. And finally, the company recently signed on SimonMed being a 170-site outpatient imaging center business operating across 10 states in the US, and Matthew Tucker will be telling us all about that deal.

(Event Instructions)

So let's get

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot